NASH Screening in Diabetes
Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk, including:
- Should We Screen for NASH?
- Role of obesity and type 2 diabetes mellitus
- Cardiovascular Risk in NAFLD/NASH
- How to Evaluate for NAFLD/NASH
- Biomarkers
- Imaging
- When/whom to biopsy?
- Management in Multidisciplinary Settings
Download the slides from this podcast at:
https://bit.ly/2ZBvVvy
See more NASH topics at:
https://bit.ly/3ezkBq6
